Integrative Approach to Dengue Hemorrhagic Fever: Clinical Management and Preventive Strategies

Authors

  • Tria Yune Medical Study Program, Malahayati University Bandar Lampung, Indonesia Author
  • Ovi Hawila Medical Study Program, Malahayati University Bandar Lampung, Indonesia Author
  • Pradita Dwi Medical Study Program, Malahayati University Bandar Lampung, Indonesia Author
  • Puteri Aulia Medical Study Program, Malahayati University Bandar Lampung, Indonesia Author
  • Putri Azizah Medical Study Program, Malahayati University Bandar Lampung, Indonesia Author
  • Putri Binta Medical Study Program, Malahayati University Bandar Lampung, Indonesia Author
  • Endah Kinarya Palupi Graduate of Science and Technology, Kwansei Gakuin University, Japan Author

DOI:

https://doi.org/10.58524/brtl.v1i1.71

Keywords:

dengue hemorrhagic fever, aedes aegypti, holistic management, pediatric patient, integrative therapy, preventive strategies

Abstract

Dengue Hemorrhagic Fever (DHF) is a viral disease transmitted by Aedes aegypti mosquitoes, presenting with a wide spectrum of clinical manifestations ranging from mild fever to severe complications such as bleeding and shock. This case report describes a 12-year-old patient who presented to the Satellite Inpatient Health Center Bandar Lampung with a three-day history of high fever, headache, joint pain, skin rash, and nausea, accompanied by a positive history of mosquito bites in a dengue-endemic area. A holistic diagnostic approach was applied, including clinical history, physical examination, and symptomatic assessment. The patient was managed with fluid therapy consisting of 1500 ml oral fluids within six hours and intravenous infusion of Ringer Lactate solution (500 cc at a rate of 20 drops per minute). Preventive measures included hospitalization for observation, avoidance of mosquito bites through nets and protective clothing, fogging, and environmental sanitation. Pharmacological therapy was prescribed, including paracetamol 500 mg three times daily, ambroxol 30 mg twice daily, vitamin C 500 mg once daily, antacid 30 ml three times daily, intravenous fluids 500 cc at 20 tpm, ranitidine 150 mg twice daily, and domperidone 10 mg twice daily. Physical examination revealed a body temperature of 39°C, petechial rash, and joint tenderness, while other parameters were within normal limits. The patient reported no history of vomiting, smoking, or alcohol consumption. Following intervention, fever and pain subsided, skin rash improved, and overall clinical condition stabilized. Preventive measures were effective in reducing mosquito exposure, while supportive therapy minimized the risk of complications. This case confirms that Aedes aegypti mosquito bites caused dengue virus infection in the patient, and demonstrates that a holistic management strategy combining pharmacological therapy, fluid replacement, preventive measures, and psychosocial support can effectively reduce symptoms and prevent complications. The novelty of this report lies in its integrative approach, emphasizing early recognition and comprehensive management as essential strategies to improve patient outcomes and reduce the burden of dengue in endemic areas.

References

Awalussiyam, H., & Hendrati, L. Y. (2024). Overview of dengue fever incidence based on population density in Indonesia. World Journal of Advanced Research and Reviews, 22(1), 1380–1386. https://doi.org/10.30574/wjarr.2024.22.1.1195

Beatty, P. R., Puerta-Guardo, H., Killingbeck, S. S., et al. (2015). Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination. Science Translational Medicine, 7(304), 304ra141. https://doi.org/10.1126/scitranslmed.aaa3787

Borré-Naranjo, D., Cárdenas-Bolívar, Y., Manzur-Barbur, M. C., Toro, E., Buendía, E., Martínez, M. C., Coronell, W., & Dueñas-Castell, C. (2022). Fluid management in dengue critical phase: Which, when, how much? International Archives of Medical Microbiology, 4(1), 15. https://doi.org/10.23937/2643-4008/1710015

Indraja, V. S., Pilladi, S., Karri, H., Niroula, P., Konidena, V. S. C., Yoganandam, S., & Kallepalli, D. D. (2025). Assessing the relationship between hematocrit and platelet count in dengue fever: A prospective observational study. World Journal of Biology Pharmacy and Health Sciences, 21(3), 32–39. https://doi.org/10.30574/wjbphs.2025.21.3.0215

Kumar, S., Bharath, R., Vajravelu, L. K., Kumar, M. D., & Banerjee, A. (2025). Key laboratory markers for early detection of severe dengue. Viruses, 17(5), 661. https://doi.org/10.3390/v17050661

Mamenun, Koesmaryono, Y., Sopaheluwakan, A., et al. (2024). Spatiotemporal characterization of dengue incidence and its correlation to climate parameters in Indonesia. Insects, 15(5), 366. https://doi.org/10.3390/insects15050366

Meloni, M., Giurato, L., Monge, L., Miranda, C., Scatena, A., Ragghianti, B., Silverii, G. A., Vermigli, C., De Cassai, A., Volpe, A., Tramonta, R., Medea, G., Bordieri, C., Falcone, M., Stefanon, L., Bernetti, A., Cappella, C., Gargiulo, M., Lorenzoni, V., & Scevola, G. (2024). Effect of a multidisciplinary team approach in patients with diabetic foot ulcers on major adverse limb events. Acta Diabetologica, 61, 543–553. https://doi.org/10.1007/s00592-024-02246-9

Ministry of Health of the Republic of Indonesia. (2021). Lampung Province dengue case report. Jakarta: Ministry of Health.

Ministry of Health of the Republic of Indonesia. (2024). Dengue fever surveillance report. Jakarta: Ministry of Health.

Parveen, S., Riaz, Z., Saeed, S., et al. (2023). Dengue hemorrhagic fever: A growing global menace. Journal of Water and Health, 21(11), 1632–1650. https://doi.org/10.2166/wh.2023.114

Salehi, M., Farkhani, E. M., Moghri, J., Ghasemian, A., Tabatabaee, S. S., & Hooshmand, E. (2025). Global dengue fever management in health systems: Identifying strategies, challenges, and solutions. BMJ Open, 15(4), e097085. https://doi.org/10.1136/bmjopen-2024-097085

Saputra, I. M. Y. (2023). Pathophysiology of dengue hemorrhagic fever: Immunological perspectives. Indonesian Journal of Tropical Medicine, 8(2), 45–53.

Shafie, A. A., Moreira, E. D., Vidal, G., Di Pasquale, A., Green, A., Tai, R., & Yoong, J. (2024). Sustainable dengue prevention and management: Integrating dengue vaccination strategies with population perspectives. Vaccines, 12(2), 184. https://doi.org/10.3390/vaccines12020184

Teo, A., Tan, H. D., Loy, T., Chia, P. Y., & Chua, C. L. L. (2023). Understanding antibody-dependent enhancement in dengue: Are afucosylated IgG1s a concern? PLOS Pathogens, 19(3), e1011223. https://doi.org/10.1371/journal.ppat.1011223

World Health Organization. (2012). Handbook for clinical management of dengue. WHO.

World Health Organization. (2022). Dengue and severe dengue. WHO. https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue

World Health Organization. (2024). Dengue – Global situation. Disease Outbreak News. https://www.who.int/emergencies/disease-outbreak-news/item/2024-DON518

World Health Organization. (2025). WHO guidelines for clinical management of arboviral diseases: Dengue, chikungunya, Zika and yellow fever. WHO. https://www.who.int/publications/i/item/9789240111110

Yulistiani, Y., Utomo, F. N., Nurhariansyah, R., Azizah, Z. T., & Permatasari, A. N. (2025). Analysis of fluid therapy in pediatric patients with dengue hemorrhagic fever. Journal of Pharmacy & Pharmacognosy Research.

Downloads

Published

2025-04-30